This bill amends Florida's controlled substances laws by adding 7-Hydroxymitragynine and xylazine to the list of Schedule I controlled substances, which are recognized for their high potential for abuse and lack of accepted medical use. It establishes new criminal penalties for the sale, manufacture, or delivery of xylazine, including a mandatory minimum term of imprisonment. The bill also introduces trafficking offenses for xylazine, with penalties that vary based on the quantity involved, and sets an effective date for these changes on July 1, 2026.

Additionally, the legislation expands the list of controlled substances to include numerous synthetic cannabinoids and related compounds, detailing specific chemical compounds and their structures. It introduces new definitions for various classes of synthetic drugs and amends trafficking laws for substances like morphine and hydrocodone, establishing specific weight thresholds for penalties. The bill aims to enhance the legal framework for controlling these substances and imposes stricter penalties for trafficking, particularly when involving minors or resulting in death. The act is set to take effect on October 1, 2026, with certain provisions effective from July 1, 2026.

Statutes affected:
S 432 Filed: 893.13, 893.135